Episode 129: Testicular Cancer Series, Pt 3 - Disseminated and relapsed/refractory disease
The Fellow on Call: The Heme/Onc Podcast
00:00
Evolution of Testicular Cancer Treatments
This chapter explores the historical progression of treatment regimens for testicular cancer, concentrating on the transition from PVB to BEP therapies. It highlights the significant improvements in cure rates and side effects, as well as the importance of ongoing research in treatment optimization. Additionally, the chapter examines the management strategies for residual and relapsed disease, addressing the implications of tumor type and size on treatment decisions.
Transcript
Play full episode
